» Articles » PMID: 28316954

Molecular Pathways Controlling Autophagy in Pancreatic Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2017 Mar 21
PMID 28316954
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the few cancer types where the 5-year survival rate shows no improvement. Despite conflicting evidence, the majority of data points to an essential role for autophagy in PDAC growth and survival, in particular constitutively activated autophagy, can provide crucial fuel to PDAC tumor cells in their nutrient-deprived environment. Autophagy, which is required for cell homeostasis, can both suppress and promote tumorigenesis and tumor survival in a context-dependent manner. Protein by protein, the mystery of how PDAC abuses the cell's homeostasis system for its malignant growth has recently begun to be unraveled. In this review, we focus on how autophagy is responsible for growth and development of PDAC tumors and where autophagy and the mechanisms controlling it fit into PDAC metabolism. Understanding the range of pathways controlling autophagy and their interplay in PDAC could open the way for new therapeutic avenues.

Citing Articles

Theranostic nanoparticles for detection and treatment of pancreatic cancer.

Agarwal H, Bynum R, Saleh N, Harris D, MacCuaig W, Kim V Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(4):e1983.

PMID: 39140128 PMC: 11328968. DOI: 10.1002/wnan.1983.


Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer.

Wang X, Ren L, Ye L, Cao J Cent Eur J Immunol. 2023; 48(3):189-202.

PMID: 37901869 PMC: 10604636. DOI: 10.5114/ceji.2023.132053.


Momordicae Semen inhibits migration and induces apoptotic cell death by regulating c-Myc and CNOT2 in human pancreatic cancer cells.

Jee W, Ko H, Park D, Park Y, Park S, Kim H Sci Rep. 2023; 13(1):12800.

PMID: 37550432 PMC: 10406802. DOI: 10.1038/s41598-023-39840-w.


Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer.

Liu Z, Parveen N, Rehman U, Aziz A, Sheikh A, Abourehab M Mol Cancer. 2023; 22(1):8.

PMID: 36635659 PMC: 9835391. DOI: 10.1186/s12943-022-01696-5.


The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches.

Koustas E, Trifylli E, Sarantis P, Papadopoulos N, Papanikolopoulos K, Aloizos G Genes (Basel). 2022; 13(10).

PMID: 36292753 PMC: 9602304. DOI: 10.3390/genes13101868.


References
1.
Fogel A, Dlouhy B, Wang C, Ryu S, Neutzner A, Hasson S . Role of membrane association and Atg14-dependent phosphorylation in beclin-1-mediated autophagy. Mol Cell Biol. 2013; 33(18):3675-88. PMC: 3753860. DOI: 10.1128/MCB.00079-13. View

2.
Johnston N, Gunasekharan V, Ravindranath A, OConnell C, Johnston P, El-Tanani M . Osteopontin as a target for cancer therapy. Front Biosci. 2008; 13:4361-72. DOI: 10.2741/3009. View

3.
Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M . Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci. 2008; 99(9):1813-9. PMC: 11159933. DOI: 10.1111/j.1349-7006.2008.00893.x. View

4.
Hausmann S, Kong B, Michalski C, Erkan M, Friess H . The role of inflammation in pancreatic cancer. Adv Exp Med Biol. 2014; 816:129-51. DOI: 10.1007/978-3-0348-0837-8_6. View

5.
Dooley H, Razi M, Polson H, Girardin S, Wilson M, Tooze S . WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1. Mol Cell. 2014; 55(2):238-52. PMC: 4104028. DOI: 10.1016/j.molcel.2014.05.021. View